Evidence map›Paper›PMID 30830442›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2018

New methods to identify high peak density artifacts in Fourier transform mass spectra and to mitigate their effects on high-throughput metabolomic data analysis.

Joshua M Mitchell, Robert M Flight, Qing Jun Wang, Richard M Higashi, Teresa W-M Fan, Andrew N Lane, Hunter N B Moseley

Abstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joshua M MitchellDepartment of Molecular & Cellular Biochemistry, University of Kentucky, Lexington, KY, USA.
Robert M FlightMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Qing Jun WangMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Richard M HigashiMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Teresa W-M FanMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Andrew N LaneMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Hunter N B MoseleyDepartment of Molecular & Cellular Biochemistry, University of Kentucky, Lexington, KY, USA. hunter.moseley@uky.edu.ORCID 0000-0003-3995-5368

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
University of Kentucky Center for Cancer MetabolismP20GM121327 · NIGMS · UNIVERSITY OF KENTUCKY · PI Binhua P Zhou · 2017 to 2026
$25.0M
SAMPLE COREU24DK097215 · NIDDK · UNIVERSITY OF KENTUCKY · PI FAN, TERESA WHEI-MEI, HIGASHI, RICHARD M · 2013 to 2017
$8.7M
Systems Biochemistry in Lung Cancer: Toward a Mechanistic Understanding of NSCLCP01CA163223 · NCI · UNIVERSITY OF LOUISVILLE · PI FAN, TERESA WHEI-MEI, FAN, TERESA WHEI-MEI · 2013 to 2017
$6.5M
Integrated Chemoselective and Informatic Platform for Large-Scale MetabolomicsR01ES022191 · NIEHS · UNIVERSITY OF LOUISVILLE · PI FAN, TERESA WHEI-MEI, HIGASHI, RICHARD M · 2012 to 2016
$3.4M
Differential Abundance Methods for Large Heterogeneous-Featured Metabolomics DatasetsR03CA211835 · NCI · UNIVERSITY OF KENTUCKY · PI FLIGHT, ROBERT MAXWELL, WANG, CHI · 2016 to 2016
$146k
American Heart Association AHA16GRNT31310020National Science Foundation 1252893NCATS NIH HHS UL1 TR001998NCI NIH HHS P01 CA163223NCI NIH HHS P30 CA177558NCI NIH HHS R03 CA211835NIDDK NIH HHS U24 DK097215NIEHS NIH HHS R01 ES022191NIGMS NIH HHS P20 GM121327NIH HHS 1R01ES022191-01NIH HHS 1R03CA211835-01NIH HHS 1U24DK097215-01A1NIH HHS UL1TR001998-01
6 · The paper itself

Abstract

introductionDirect injection Fourier-transform mass spectrometry (FT-MS) allows for the high-throughput and high-resolution detection of thousands of metabolite-associated isotopologues. However, spectral artifacts can generate large numbers of spectral features (peaks) that do not correspond to known compounds. Misassignment of these artifactual features creates interpretive errors and limits our ability to discern the role of representative features within living systems.

objectivesOur goal is to develop rigorous methods that identify and handle spectral artifacts within the context of high-throughput FT-MS-based metabolomics studies.

resultsWe observed three types of artifacts unique to FT-MS that we named high peak density (HPD) sites: fuzzy sites, ringing and partial ringing. While ringing artifacts are well-known, fuzzy sites and partial ringing have not been previously well-characterized in the literature. We developed new computational methods based on comparisons of peak density within a spectrum to identify regions of spectra with fuzzy sites. We used these methods to identify and eliminate fuzzy site artifacts in an example dataset of paired cancer and non-cancer lung tissue samples and evaluated the impact of these artifacts on classification accuracy and robustness.

conclusionOur methods robustly identified consistent fuzzy site artifacts in our FT-MS metabolomics spectral data. Without artifact identification and removal, 91.4% classification accuracy was achieved on an example lung cancer dataset; however, these classifiers rely heavily on artifactual features present in fuzzy sites. Proper removal of fuzzy site artifacts produces a more robust classifier based on non-artifactual features, with slightly improved accuracy of 92.4% in our example analysis.

Indexed as

Fourier AnalysisHigh-Throughput Screening AssaysMass SpectrometryMetabolomicsCarcinoma, Non-Small-Cell LungHumansLungLung NeoplasmsArtifactData analysisFourier transformMass spectrometryMetabolomics

Identifiers

PMID30830442
PMCPMC6153687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.